HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 217 filers reported holding HERBALIFE LTD in Q1 2023. The put-call ratio across all filers is 3.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,112 | +112.7% | 151 | +101.3% | 0.00% | – |
| Q2 2023 | $993 | -86.1% | 75 | -83.1% | 0.00% | – |
| Q1 2023 | $7,165 | +8.2% | 445 | 0.0% | 0.00% | – |
| Q4 2022 | $6,622 | +562.2% | 445 | +1012.5% | 0.00% | – |
| Q3 2022 | $1,000 | -80.0% | 40 | -82.4% | 0.00% | – |
| Q2 2022 | $5,000 | -16.7% | 227 | +12.4% | 0.00% | – |
| Q1 2022 | $6,000 | -25.0% | 202 | +4.7% | 0.00% | – |
| Q4 2021 | $8,000 | +14.3% | 193 | +20.6% | 0.00% | – |
| Q3 2021 | $7,000 | -30.0% | 160 | -11.6% | 0.00% | – |
| Q2 2021 | $10,000 | +66.7% | 181 | +27.5% | 0.00% | – |
| Q1 2021 | $6,000 | -14.3% | 142 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | +16.7% | 142 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | 0.0% | 142 | -39.1% | 0.00% | – |
| Q1 2020 | $6,000 | -82.9% | 233 | -68.7% | 0.00% | -100.0% |
| Q4 2019 | $35,000 | +29.6% | 744 | +4.5% | 0.00% | +50.0% |
| Q3 2019 | $27,000 | +125.0% | 712 | +152.5% | 0.00% | +100.0% |
| Q2 2019 | $12,000 | +33.3% | 282 | +60.2% | 0.00% | 0.0% |
| Q1 2019 | $9,000 | – | 176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |